Correlation Between SynCore Biotechnology and MPI

Can any of the company-specific risk be diversified away by investing in both SynCore Biotechnology and MPI at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SynCore Biotechnology and MPI into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between SynCore Biotechnology Co and MPI Corporation, you can compare the effects of market volatilities on SynCore Biotechnology and MPI and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SynCore Biotechnology with a short position of MPI. Check out your portfolio center. Please also check ongoing floating volatility patterns of SynCore Biotechnology and MPI.

Diversification Opportunities for SynCore Biotechnology and MPI

-0.42

Correlation Coefficient

SynCore Biotechnology  MPI

Very good diversification

The 3 months correlation between SynCore and MPI is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding SynCore Biotechnology Co and MPI Corp. in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MPI Corporation and SynCore Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SynCore Biotechnology Co are associated (or correlated) with MPI. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MPI Corporation has no effect on the direction of SynCore Biotechnology i.e., SynCore Biotechnology and MPI go up and down completely randomly.

Pair Corralation between SynCore Biotechnology and MPI

Assuming the 90 days trading horizon SynCore Biotechnology Co is expected to under-perform the MPI. But the stock apears to be less risky and, when comparing its historical volatility, SynCore Biotechnology Co is 1.46 times less risky than MPI. The stock trades about -0.04 of its potential returns per unit of risk. The MPI Corporation is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest  16,590  in MPI Corporation on October 4, 2024 and sell it today you would earn a total of  76,010  from holding MPI Corporation or generate 458.17% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

SynCore Biotechnology Co  vs.  MPI Corp.

SynCore Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days SynCore Biotechnology Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

MPI Corporation

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in MPI Corporation are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, MPI showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with SynCore Biotechnology and MPI

The main advantage of trading using opposite SynCore Biotechnology and MPI positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SynCore Biotechnology position performs unexpectedly, MPI can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MPI will offset losses from the drop in MPI's long position.

The idea behind SynCore Biotechnology Co and MPI Corporation pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.